ACP5 and prostate neoplasm: Studies have demonstrated that treatment with hPAP-expressing HSV bPΔ6-hPAP not only significantly reduced tumor growth and increased survival in C57/BL6 mice bearing mouse TRAMP-C2 prostate tumors but also reduced the size of tumor nodules of mice bearing metastatic TRAMP-C2 lung tumors [186].